Galera Therapeutics Restructures Leadership and Cuts Costs
Company Announcements

Galera Therapeutics Restructures Leadership and Cuts Costs

Galera Therapeutics (GRTX) has provided an update.

Galera Therapeutics, Inc. is streamlining its operations amidst a strategic review by eliminating the COO position held by Dr. Robert A. Beardsley to cut costs. Dr. Beardsley is set to receive severance as per his employment agreement, and may continue to provide consulting services to the company. The report includes forward-looking statements, and actual outcomes may vary due to various risks and uncertainties highlighted in the company’s latest annual report.

See more insights into GRTX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyUroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
TipRanks Auto-Generated NewsdeskGalera Therapeutics Announces Wind-Up and Special Stockholder Meeting
TheFlyGalera Therapeutics reports Q2 EPS (7c) vs. (48c) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App